SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017818
Filing Date
2016-05-05
Accepted
2016-05-05 09:01:49
Documents
60
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20160331.htm 10-Q 1843448
2 EX-10.35 rgnx-ex1035_282.htm EX-10.35 90751
3 EX-31.1 rgnx-ex311_10.htm EX-31.1 16915
4 EX-31.2 rgnx-ex312_8.htm EX-31.2 16716
5 EX-32.1 rgnx-ex321_9.htm EX-32.1 10336
6 GRAPHIC gien2avmpopn000001.jpg GRAPHIC 15822
  Complete submission text file 0001564590-16-017818.txt   6380463

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgnx-20160331.xml EX-101.INS 1338913
8 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20160331.xsd EX-101.SCH 40310
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20160331_cal.xml EX-101.CAL 47500
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20160331_def.xml EX-101.DEF 163997
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20160331_lab.xml EX-101.LAB 336432
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20160331_pre.xml EX-101.PRE 260702
Mailing Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9712 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 161621802
SIC: 2836 Biological Products, (No Diagnostic Substances)